Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized, Open Label Trial Comparing the Effects of Intermittent Vismodegib Versus PDT on the Maintenance of Benefit Following 7 Months of Continuous Vismodegib Treatment in Patients With Multiple Basal Cell Carcinomas

NCT01556009 is registered in ClinicalTrials.gov with UCSF Benioff Children's Hospital Oakland as lead sponsor.

NCT NCT01556009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01556009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized, Open Label Trial Comparing the Effects of Intermittent Vismodegib Versus PDT on the Maintenance of Benefit Following 7 Months of Continuous Vismodegib Treatment in Patients With Multiple Basal Cell Carcinomas
Lead sponsor
UCSF Benioff Children's Hospital Oakland
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2012
Completion date
December 31, 2015
Enrollment
24 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell nevus syndrome, gorlin's syndrome